Timothy J. Sangiovanni, VP, Corporate Controller at KEMPHARM, INC (KMPH), bought 8,000 shares at $0.25 ($2K) on 2020-03-09, disclosed to the SEC on 2020-03-10.
Open-market purchase of $2k KMPH by VP, Corporate Controller. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.25 | 333 | $83 | 4.0% |
| 2 | $0.25 | 10 | $3 | 0.1% |
| 3 | $0.26 | 7,657 | $2K | 95.9% |
| Total | $0.26 avg | 8,000 | $2K | 100% |
| Filing → |
| ZVRA | SELL | 2025-02-14 | $24K | — | Filing → |
| ZVRA | BUY | 2023-03-13 | $5K | — | Filing → |
| KMPH | BUY | 2020-03-16 | $800 | — | Filing → |